Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.
Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.
HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.